Loibl S - Search Results

1

Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765).

Noske A, Loibl S, Darb-Esfahani S, Roller M, Kronenwett R, Müller BM, Steffen J, von Toerne C, Wirtz R, Baumann I, Hoffmann G, Heinrich G, Grasshoff ST, Ulmer HU, Denkert C, von Minckwitz G. Noske A, et al. Among authors: loibl s. Breast Cancer Res Treat. 2011 Feb;126(1):109-17. doi: 10.1007/s10549-010-1316-y. Epub 2010 Dec 29. Breast Cancer Res Treat. 2011. PMID: 21190079 Clinical Trial.

2

Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer.

Solbach C, Roller M, Ahr A, Loibl S, Nicoletti M, Stegmueller M, Kreysch HG, Knecht R, Kaufmann M. Solbach C, et al. Among authors: loibl s. Int J Cancer. 2002 Oct 1;101(4):390-4. doi: 10.1002/ijc.10615. Int J Cancer. 2002. PMID: 12209965 Free article.

3

Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy.

Loibl S, von Minckwitz G, Weber S, Sinn HP, Schini-Kerth VB, Lobysheva I, Nepveu F, Wolf G, Strebhardt K, Kaufmann M. Loibl S, et al. Cancer. 2002 Sep 15;95(6):1191-8. doi: 10.1002/cncr.10817. Cancer. 2002. PMID: 12216084 Free article.

4

Adjuvant hormone therapy following primary therapy for endometrial cancer.

Loibl S, von Minckwitz G, Kaufmann M. Loibl S, et al. Eur J Cancer. 2002 Nov;38 Suppl 6:S41-3. doi: 10.1016/s0959-8049(02)00281-2. Eur J Cancer. 2002. PMID: 12409070 No abstract available.

5

EGF-R and Her2/neu overexpressing tumors: independent collectives for treatment of breast cancer by specific monoclonal antibody-therapy.

Solbach C, Roller M, Budischewski K, Loibl S, Nicoletti M, Stegmueller M, Kaufmann M. Solbach C, et al. Among authors: loibl s. J Cancer Res Clin Oncol. 2003 Apr;129(4):250-1. doi: 10.1007/s00432-003-0421-2. Epub 2003 Apr 23. J Cancer Res Clin Oncol. 2003. PMID: 12709794

6

[New strategies for therapy of breast cancer. San Antonio Breast Cancer Symposium, 2002].

Loibl S, von Minckwitz G, Kaufmann M. Loibl S, et al. Zentralbl Gynakol. 2002 Oct;124(10):451-3. doi: 10.1055/s-2002-38914. Zentralbl Gynakol. 2002. PMID: 12712385 German. No abstract available.

7

[New aspects of carcinoma of the breast therapy and of gynaecological carcinoma treatment].

Loibl S, Von Minckwitz G, Kaufmann M. Loibl S, et al. Zentralbl Gynakol. 2003 Sep;125(9):346-52. doi: 10.1055/s-2003-43042. Zentralbl Gynakol. 2003. PMID: 14569516 German.

8

Mitomycin C, 5-fluorouracil and folinic acid (Mi-Fu-Fo) as salvage chemotherapy in breast cancer patients with liver metastases and impaired hepatic function: a phase II study.

Loibl S, von Minckwitz G, Schwedler K, Schmidt KA, Höper D, Kaufmann M, Costa SD. Loibl S, et al. Anticancer Drugs. 2004 Aug;15(7):719-24. doi: 10.1097/01.cad.0000136692.99971.ec. Anticancer Drugs. 2004. PMID: 15269604 Clinical Trial.

9

Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer.

Welt A, von Minckwitz G, Oberhoff C, Borquez D, Schleucher R, Loibl S, Harstrick A, Kaufmann M, Seeber S, Vanhoefer U. Welt A, et al. Among authors: loibl s. Ann Oncol. 2005 Jan;16(1):64-9. doi: 10.1093/annonc/mdi024. Ann Oncol. 2005. PMID: 15598940 Free article. Clinical Trial.

10

The role of early expression of inducible nitric oxide synthase in human breast cancer.

Loibl S, Buck A, Strank C, von Minckwitz G, Roller M, Sinn HP, Schini-Kerth V, Solbach C, Strebhardt K, Kaufmann M. Loibl S, et al. Eur J Cancer. 2005 Jan;41(2):265-71. doi: 10.1016/j.ejca.2004.07.010. Eur J Cancer. 2005. PMID: 15661552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

531 results

Search Page